For instance, reprogramming of the glutamine-proline-arginine metabolic circuit has been associated with cancer and found to be regulated by TP53 and MYC, in which proline acts as the regulatory axis of this circuit [27, 28]. This evidence concerns the gene TP53 and cancer.